Month: June 2025

WEST PALM BEACH, Fla., June 24, 2025 (GLOBE NEWSWIRE) — Sunrise Realty Trust, Inc. (“SUNS”) (Nasdaq: SUNS), a lender on the Tannenbaum Capital Group (“TCG”) Real Estate platform, today announced that it will release its financial results for the second quarter ending June 30, 2025 on Thursday, August 7th, 2025 before market open. Management will review SUNS’ financial results at 10:00 am ET via webcast available on the Investor Relations website at ir.sunriserealtytrust.com. Participants are also invited to access the conference call by registering in advance at this link. A replay will be available one hour after the event. SUNS distributes its earnings releases via its website and email lists. Those interested in receiving firm updates by email can sign up for them here. About Sunrise Realty Trust, Inc. Sunrise Realty Trust,...

Parsons and IBM join forces to design solutions for a national airspace system with enhanced safety and efficiency CHANTILLY, Va., June 24, 2025 (GLOBE NEWSWIRE) — Today, Parsons Corporation (NYSE: PSN) and IBM (NYSE: IBM) announced a collaboration to deliver on President Donald Trump’s and Transportation Secretary Sean Duffy’s vision for a brand new, state of-the-art air traffic control system. This collaboration directly responds to Secretary Duffy’s call for world-class innovators to rapidly spearhead the overhaul of the Federal Aviation Administration’s (FAA) National Airspace System (NAS), prioritizing an open vendor agnostic approach that enables the agency to leverage the latest technologies and continuously improve their systems based on real-time feedback and evolving needs. Parsons would serve as the prime contractor...

PARIS, June 24, 2025 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) is proud to announce that it has been recognized with three awards at the 2025 edition of Airbus’ Supply Chain & Quality Improvement Program (SQIP), held in early June. The program honors suppliers that consistently deliver excellence in their quality & delivery performance and industrial maturity. Constellium’s facilities in Issoire and Montreuil-Juigné were honored for their significant contributions to Airbus’ supply chain: Issoire – Accredited Supplier AwardFor the second consecutive year, the Issoire plant received the “Accredited Supplier” award – the highest Airbus SQIP program distinction. This recognition highlights the facility’s sustained excellence and reliability over time with regards to performance. Issoire – Sustainability Special Recognition     ...

– RDEB is a lifelong debilitating, blistering skin disease associated with large and painful wounds that often remain open for years and cause significant clinical burden, including pain, itch, and risk of squamous cell carcinoma – – ZEVASKYN™ (prademagene zamikeracel) demonstrated significant wound healing and pain reduction after a single treatment with a favorable safety profile in large chronic RDEB wounds – – ZEVASKYN is the first and only autologous cell-based gene therapy FDA-approved to treat RDEB wounds in adult and pediatric patients – CLEVELAND, June 24, 2025 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that The Lancet has published results from the pivotal Phase 3 VIITAL study (NCT04227106) evaluating the efficacy and safety of ZEVASKYN (prademagene...

WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced the appointment of Steve Silvestro, currently serving as the Company’s Chief Executive Officer, to its Board of Directors, effective as of June 20, 2025. Mr. Silvestro joined the Company in 2019 and has been the Company’s CEO since March 2025, after serving as the interim CEO from January 2025. The appointment of Mr. Silvestro, with his knowledge of the Company and expertise in the industry, will enhance overall leadership and greatly contribute to the Company’s ability to execute its value creation plans and support key initiatives to deliver on its customer and shareholder...

Comprehensive restructuring eliminates the potential issuance of up to 1.5 billion shares of common stock Plus Therapeutics files a request to withdraw the related resale registration statement with the SEC HOUSTON, June 24, 2025 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, announces a comprehensive restructuring of its previous $15 million equity financing announced on March 4, 2025. This strategic restructuring eliminates potential dilution of up to 1.5 billion shares of common stock, which the Company believes will significantly enhance shareholder value and position the Company to move forward with a more straightforward equity capital structure. KEY...

Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medications TARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the launch of a pioneering matching program for donations to Good Days, an independent national non-profit charitable organization, to support Good Days’ Retinal Vascular and Neovascular Disease Fund. Through this initiative, Regeneron has committed to matching donations up to a total of $200 million at a one-to-one rate for the remainder of the 2025 calendar year, enabling more patients to affordably access essential medicines that help protect their vision. “We are proud to support Good Days with this unprecedented philanthropic effort,” said Leonard Schleifer, M.D., Ph.D., Board Co-Chair, President...

TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX.V: LAB | OTCQB: NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce the appointment of Ryan Weston as Vice President Exploration of the Company. Ryan brings over 20 years of global experience in base and precious metals exploration to the Company. He played key roles in the successful sale of Carlisle Goldfields to Alamos Gold for CAD $28 million in 2016, and of Noront Resources to Wyloo Metals for CAD $686 million in 2022. Most recently, he served as Vice President Exploration at Wyloo, where he led exploration initiatives in Ontario’s Ring of Fire region. Ryan is a registered P.Geo. in Ontario and holds an MBA from Queen’s University, an M.Sc. from Laurentian University, and a B.Sc. from the University of Toronto. “I am thrilled to be joining...

NEW YORK and MELBOURNE, Australia, June 24, 2025 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL) (“Incannex” or the “Company”), a clinical-stage biopharmaceutical company advancing combination drug therapies for high-impact indications, announces the appointment of Douglas B. Kirsch, M.D., FAAN, FAASM to its IHL-42X Obstructive Sleep Apnea (OSA) Clinical Advisory Board. “We are honored to welcome Dr. Kirsch to the IHL-42X Clinical Advisory Board,” stated Dr. Lou Barbato, Incannex Chief Medical Officer. “His extensive clinical experience and leadership within the sleep medicine community will be instrumental as we advance IHL-42X through late-stage development. With his addition, our advisory board continues to strengthen its depth of expertise at a pivotal time for the program.” Dr. Kirsch is a recognized authority in...

Ships Backlog of 800G Optical Engine Samples to Customers TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Corporation”) (TSX Venture: PTK; NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced that it has signed a Master Agreement, Module Purchase Agreement and a Deed of Consignment with NationGate Solutions (M) Sdn. Bhd (“NationGate”), to manufacture optical engine assemblies for POET in Penang, Malaysia. POET has engaged with NationGate to assemble and test consigned optical engines with a custom-designed fiber-attach unit (FAU) made specifically for one of POET’s key customers. That customer has confirmed a high level of interest from hyperscale data centers in a product that includes...